HERMIONE EXCHANGE PROGRAMME:DISCUSSING CRITICAL CASES TO FIND THE SOLUTION.

1. 1.Bidard FC, Kaklamani VG, Neven P, Streich G, Montero AJ, Forget F, Mouret-Reynier MA, Sohn JH, Taylor D, Harnden KK, Khong H, Kocsis J, Dalenc F, Dillon PM, Babu S, Waters S, Deleu I, García Sáenz JA, Bria E, Cazzaniga M, Lu J, Aftimos P, Cortés J, Liu S, Tonini G, Laurent D, Habboubi N, Conlan MG, Bardia A.. Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.. J Clin Oncol. 2022 Oct 1;40(28):3246-3256. doi: 10.1200/JCO.22.00338. Epub 2022 May 18. Erratum in: J Clin Oncol. 2023 Aug 10;41(23):3962. PMID: 35584336; PMCID: PMC9553388.. 2023
   Articolo scientificoJ Clin Oncol. 2022 Oct 1;40(28):3246-3256. doi: 10.1200/JCO.22.00338. Epub 2022 May 18. Erratum in: J Clin Oncol. 2023 Aug 10;41(23):3962. PMID: 35584336; PMCID: PMC9553388.Leggi il PDF gratuito
2. 2.Venetis K, Pepe F, Pescia C, Cursano G, Criscitiello C, Frascarelli C, Mane E, Russo G, Taurelli Salimbeni B, Troncone G, Guerini Rocco E, Curigliano G, Fusco N, Malapelle U.. ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing. Cancer Treat Rev. 2023. Dec;121:102642. doi: 10.1016/j.ctrv.2023.102642. Epub 2023 Oct 13. PMID: 37864956. 2023
   Articolo scientificoDec;121:102642. doi: 10.1016/j.ctrv.2023.102642. Epub 2023 Oct 13. PMID: 37864956Leggi il paperCerca versione gratuita
3. 3.Pagni F, Guerini-Rocco E, Schultheis AM, Grazia G, Rijavec E, Ghidini M, Lopez G, Venetis K, Croci GA, Malapelle U, Fusco N.. Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers.. Int J Mol Sci. 2019 Nov 1;20(21):5452. doi: 10.3390/ijms20215452. PMID: 31683784; PMCID: PMC6862285.. 2019
   Articolo scientificoInt J Mol Sci. 2019 Nov 1;20(21):5452. doi: 10.3390/ijms20215452. PMID: 31683784; PMCID: PMC6862285.Leggi il PDF gratuito
4. 4.Fusco N, Ragazzi M, Sajjadi E, Venetis K, Piciotti R, Morganti S, Santandrea G, Fanelli GN, Despini L, Invernizzi M, Cerbelli B, Scatena C, Criscitiello C.. Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.. Histol Histopathol. 2021 Dec;36(12):1235-1245. doi: 10.14670/HH-18-376. Epub 2021 Sep 29. PMID: 34585734.. 2021
   Articolo scientificoHistol Histopathol. 2021 Dec;36(12):1235-1245. doi: 10.14670/HH-18-376. Epub 2021 Sep 29. PMID: 34585734.Cerca su Google Scholar

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).